Titlebook: Cost Versus Benefit in Cancer Care; Basil A. Stoll (Honorary Consulting Physician) Textbook 1988Latest edition The Editor and the Contribu

oncologist

What is Overtreatment in Cancer?elatives, professional colleagues and not least, from desperate patients themselves. They also come from the professional need to appear busy even when little can be achieved, and from the scientific need to develop new diagnostic or treatment methods. Yet, many physicians believe that treatment sho

小臼

What is Best for the Patient? A United States View1981 survived for at least five years, compared with an estimated 38% in 1960–1963 [5]. However, the number of patients that have state-of-the-art therapy available to them is still relatively small because of the great variability in the expertise and resources within our health care system. The Na

fluffy

What is Best for the Patient? A European Viewical care, in the extent to which health services are privatised or nationalised, and in the approach to management by doctors. There is also a substantial variation in clinical management within national boundaries, probably more so than in the USA where a more informed, voluble and demanding socie

radiograph

The Patient’s Expectations in the United Statesrom the society at large that are utterly unrealistic on a day-to-day basis. They are asked to be Renaissance men and women in an age when that is no longer possible; they are expected to be ultimate healers, technological wizards, total authorities. (When a physician refuses to accept those expecta

憤慨一下

法律的瑕疵

Focus on Clinical Trialsresearch now proceeds through various ‘phases’ and this process is regarded as critical to the development of new forms of treatment. To measure the costs and benefits of clinical cancer research is complex, and must be tackled from the perspective of society as well as from that of the individual p

陰險

逃避責任

CUB

Rationing Cancer Care: A United States Viewn. They differ only in the instruments which they employ to accomplish their objective of allocating scarce resources among competing needs. A capitalist society such as the USA which relies heavily on ‘the market’ to perform the rationing, is restrained from doing so in the case of health services

languid

Rationing Cancer Care: A European Viewther than demand. As an example, the British expenditure on chemotherapy in cancer is on a per capita basis, reported to be only about one-fifth as much as in the USA [1], and such a finding makes one ask whether it results from different resource availability or from different treatment objectives